Prognostic Value of Systemic Inflammation Score for Esophageal Cancer Patients Undergoing Surgery: A Systematic Review and Meta-Analysis

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):1–7. doi:10.3322/CAAC.21492.
   Web of Science ®Google Scholar
• Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–1021. doi:10.1007/S12328-020-01237-X.
   PubMed Web of Science ®Google Scholar
• Kelly RJ. Emerging Multimodality Approaches to Treat Localized Esophageal Cancer. J Natl Compr Canc Netw. 2019;17(8):1009–1014. doi:10.6004/JNCCN.2019.7337.
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Zhang H, Fan D. Prognostic markers in esophageal cancer: from basic research to clinical use. Expert Rev Gastroenterol Hepatol. 2015;9(7):887–889. doi:10.1586/17474124.2015.1041507.
   PubMed Web of Science ®Google Scholar
• Hernández M, Martín R, García-Cubillas MD, Maeso-Hernández P, Nieto ML. Secreted PLA2 induces proliferation in astrocytoma through the EGF receptor: another inflammation-cancer link. Neuro Oncol. 2010;12(10):1014–1023. doi:10.1093/NEUONC/NOQ078.
   PubMed Web of Science ®Google Scholar
• Liu S, Li C, Zhang P. Enhanced recovery after surgery for hip fractures: a systematic review and meta-analysis. Perioper Med (London, England). 2021;10(1):31. doi:10.1186/S13741-021-00201-8.
   Google Scholar
• Eltohami YI, Kao HK, Lao WWK, et al. The prediction value of the systemic inflammation score for oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg. 2018;158(6):1042–1050. doi:10.1177/0194599817751678.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shi SM, Yang H, et al. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection. J Cancer. 2019;10(2):494–503. doi:10.7150/JCA.26890.
   PubMed Web of Science ®Google Scholar
• Markus M, Abendroth A, Noureddine R, et al. Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy. J Cancer Res Clin Oncol. 2021;147(2):579–591. doi:10.1007/S00432-020-03361-0.
   PubMed Web of Science ®Google Scholar
• Liu C, Li X. Stage-Dependent changes in albumin, NLR, PLR, and AFR are correlated with shorter survival in patients with gastric cancer. Clin Lab. 2019;65(09/2019):1623–1633. doi:10.7754/Clin.Lab.2019.190132.
   Google Scholar
• Aoyama T, Ju M, Komori K, et al. The systemic inflammation score is an independent prognostic factor for esophageal cancer patients who receive curative treatment. Anticancer Res. 2022;42(5):2711–2717. doi:10.21873/ANTICANRES.15749.
   PubMed Web of Science ®Google Scholar
• Xiong J, Kang W, Ma F, et al. Modified systemic inflammation score is an independent predictor of long-term outcome in patients undergoing surgery for adenocarcinoma of the esophagogastric junction. Front Surg. 2021;8:622821. doi:10.3389/fsurg.2021.622821.
   PubMed Web of Science ®Google Scholar
• Nomoto D, Baba Y, Akiyama T, et al. Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients. Ann Gastroenterol Surg. 2021;5(5):669–676. doi:10.1002/AGS3.12464.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. doi:10.1016/j.ijsu.2021.105906.
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed October 30, 2020.
   Google Scholar
• Tsuchiya N, Kunisaki C, Sato S, et al. Feasibility of esophagectomy for esophageal cancer in elderly patients: a case-control study. Langenbecks Arch Surg. 2021;406(8):2687–2697. doi:10.1007/S00423-021-02271-0.
   PubMed Web of Science ®Google Scholar
• Kanda M, Koike M, Tanaka C, et al. Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus. Ann Surg Oncol. 2019;26(13):4773–4781. doi:10.1245/S10434-019-07914-7.
   PubMed Web of Science ®Google Scholar
• Fu X, Li T, Dai Y, Li J. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma. BMC Cancer. 2019;19(1):721. doi:10.1186/s12885-019-5940-6.
   Google Scholar
• Guo XW, Liu YC, Gao F, et al. Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma. Cancer Manag Res. 2018;10:2409–2418. doi:10.2147/CMAR.S167179.
   PubMed Web of Science ®Google Scholar
• Han L, Song Q, Jia Y, et al. The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma. Tumour Biol. 2016;37(3):3081–3090. doi:10.1007/S13277-015-4152-1.
   PubMedGoogle Scholar
• Mullaney PJ, Wadley MS, Hyde C, et al. Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancer. Union Internacional Contra la Cancrum/American Joint Committee on Cancer. Br J Surg. 2002;89(11):1405–1408. doi:10.1046/J.1365-2168.2002.02262.X.
   PubMed Web of Science ®Google Scholar
• Zhang G, Zhang C, Wang L, et al. The prognostic value of tumor deposits and the impact on the TNM classification system in esophageal cancer patients. J Surg Oncol. 2021;123(4):891–903. doi:10.1002/JSO.26376.
   PubMed Web of Science ®Google Scholar
• McMillan DC. Cancer and systemic inflammation: stage the tumour and stage the host. Br J Cancer. 2013;109(3):529. doi:10.1038/BJC.2013.418.
   PubMed Web of Science ®Google Scholar
• Yodying H, Matsuda A, Miyashita M, et al. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol. 2016;23(2):646–654. doi:10.1245/S10434-015-4869-5.
   PubMed Web of Science ®Google Scholar
• Powell AGMT, Eley C, Chin C, et al. Prognostic significance of serum inflammatory markers in esophageal cancer. Esophagus. 2021;18(2):267–277. doi:10.1007/S10388-020-00772-3.
   PubMed Web of Science ®Google Scholar
• Shang QX, Yang YS, Hu WP, et al. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients. Transl Cancer Res. 2020;9(6):3903–3914. doi:10.21037/TCR-19-2777.
   PubMed Web of Science ®Google Scholar
• Chen YR, Chen YL, Ouyang SS, et al. Prognostic efficacy of preoperative mGPS, SIS and LCS in patients with gastric cancer. Clin Chim Acta. 2020;511:81–89. doi:10.1016/J.CCA.2020.09.027.
   PubMed Web of Science ®Google Scholar
• Ma M, Weng M, Chen F, et al. Systemic inflammation score is a prognostic marker after curative resection in gastric cancer. ANZ J Surg. 2019;89(4):377–382. doi:10.1111/ANS.15103.
   PubMed Web of Science ®Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137–148. doi:10.1016/J.IMMUNI.2004.07.017.
   PubMed Web of Science ®Google Scholar
• Azimi F, Scolyer RA, Rumcheva P, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30(21):2678–2683. doi:10.1200/JCO.2011.37.8539.
   PubMed Web of Science ®Google Scholar
• Evani SJ, Prabhu RG, Gnanaruban V, Finol EA, Ramasubramanian AK. Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow. FASEB J. 2013;27(8):3017–3029. doi:10.1096/FJ.12-224824.
   PubMed Web of Science ®Google Scholar
• Augier S, Ciucci T, Luci C, Carle GF, Blin-Wakkach C, Wakkach A. Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillance. J Immunol. 2010;185(12):7165–7173. doi:10.4049/JIMMUNOL.0902583.
   PubMed Web of Science ®Google Scholar